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Increased atrial natriuretic peptide mRNA expression in the
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Increased atrial natriuretic peptide mRNA expression in the kidney of
diabetic rats. To investigate whether renal synthesis of atrial natriuretiC
peptide (ANP) is influenced in diabetes, we measured renal ANP mRNA
levels, urine volume, urinary ANP and sodium excretion rates in strepto-
zotocin (STZ)-induced diabetic rats. By using reverse transcription-
polymerase chain reaction (RT-PCR) followed by Southern blot analysis,
we found that renal cortical and outer medullary ANP mRNA levels in
untreated diabetic rats were markedly increased as early as the second day
after the onset of hyperglycemia and remained elevated for the entire
42-day study period. Plasma AMP concentrations in untreated diabetic
rats were increased on the 42nd day, whereas plasma renin activity were
suppressed. The urine volume, urinary ANP and sodium excretion rates in
untreated diabetic rats were also significantly elevated on the second day
and remained elevated for the entire 42-day study period. Urinary ANP
excretion rates were well correlated with urine volume, and urinary
sodium excretion rate in normal rats and diabetic rats on days 2, 4, 7, 14
and 42. Our results indicate that renal ANP mRNA expression is
enhanced in diabetic rats, and that renal-synthesized AMP as one of
regulators to handle water and sodium balance in diabetic rats is worthy of
further investigation.
Atrial natriuretic peptide (ANP), a peptide with potent di-
uretic, natriuretic, vasorelaxant, and aldosterone-inhibitory activ-
ities [1—3], is secreted primarily by the cardiac atria [4]. With the
immunocytochemical technique and the availability of cDNA
probes, the presence of proANP-like immunoreactive peptide and
ANP mRNA were demonstrated in extra-atrial tissues [5—8].
More recently, several studies have provided evidences suggesting
that the kidney is also a site of ANP synthesis [9—12] and that
renal synthesized ANP may contribute to the regulation of renal
sodium excretion [12]. Several investigators have indicated that
circulating ANP concentration does not correlate with the degree
of natriuresis in the physiological, and pathophysiological condi-
tions [13—16]. In contrast, urine urodilatin (ANP-95 to 126), a
natriuretic peptide of renal origin, excretion closely parallels renal
sodium excretion under various conditions that influence body
fluid regulation [16—18]. There have also been reports showing
that most of the circulating ANP was degraded in the kidney, as
the proximal tubule contained potent ANP degrading enzyme and
the natriuretic peptide receptor C subtype (NPR-C) were distrib-
uted over the vascular endothelium [19, 20]. Using reverse
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transcription-polymerase chain reaction (RT-PCR) followed by
Southern blot analysis, we recently demonstrated that renal ANP
mRNA levels and urinary ANP excretion rates markedly in-
creased in rats with deoxycorticosterone acetate-salt (DOCA-salt)
treatment [21]. The urinary ANP excretion rate was also found to
be well correlated with urinary sodium excretion rate in DOCA-
salt rats. These observations suggest that renal-synthesized natri-
uretic peptide, in addition to circulating ANP, may have a role in
the renal regulation of sodium homeostasis.
In animals with experimental diabetes, increased plasma vol-
ume and exchangeable sodium have been found [22] and have
been thought to lead to changes in plasma ANP concentration
[22—24] and cardiac ANP mRNA expression [25] in the early stage
of diabetes. In an attempt to find out whether intrarenal ANP
synthesis is influenced in severely hyperglycemic diabetic rats, we
measured renal ANP mRNA levels, urinary ANP excretion rates
and circulating ANP levels in STZ-induced diabetic rats.
Methods
Animal experiments
Male Wistar rats weighing 260 to 320 g were individually
housed in metabolic cages. Diabetes was induced by a single
peritoneal injection of 55 mg/kg STZ (Sigma Chemical Co., St.
Louis, MO, USA). Twenty-four hours later, induction of diabetes
was confirmed by the measurement of their tail blood glucose
levels (Yellow Springs Instrument Co., Inc., Yellow Springs, OH,
USA). Rats with blood glucose levels > 19.4 mmol/liter were
included. Diabetic rats were randomly assigned to one of two
groups: untreated diabetic rats (UT-DM, N = 24) and insulin-
treated diabetic rats (IT-DM, N = 11). Rats in the IT-DM group
received insulin (heat-treated bovine ultralente insulin; Novo-
Nordisk, Copenhagen, Denmark) designed to achieve blood
glucose levels between 4.5 and 8.3 mmol/liter. Eighteen body wt
and age-matched rats were studied as normal controls (NC). In
Experiment 1, rats (NC, N = 6; UT-DM, N = 7; IT-DM, N = 6)
were sacrificed by decapitation to collect blood for the measure-
ments of plasma ANP and plasma renin activity (PRA) on day 42
after STZ or citric buffer injection, and atria, ventricles, kidney
cortex and outer medulla were immediately removed for ANP
mRNA analysis. Urine sodium, and ANP immunoreactivity were
also measured on days 2, 4, 7, 14, and 42 in three groups. In
Experiment 2, rats from the UT-DM group were sacrificed on
days 2 (N = 4), 4 (N = 2), 7 (N = 2), and 14 (N = 2), and from
the NC group on days 2 (N = 3) and 14 (N = 3) for renal AMP
mRNA determination. In Experiment 3, for the measurement of
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glomerular filtration rate, seven rats from the UT-DM group, five
from the IT-DM group and six from the NC group were studied
from weeks 4 and 6 after injection of STZ or citric buffer.
RNA isolation and reverse transcription
Total RNA was extracted from the renal cortex, outer medulla,
atrium and ventricle by a modified guanidium isothiocyanate
method [26]. Two micrograms of total RNA from each sample
were reverse transcribed by incubating with 20 jkl reverse tran-
scription mixture containing: 20 pmole oligo (dT)18 primer, 50 mvt
Tris-HCI (pH 8.3), 75 mist KCI, 3 mist MgCl2, 20 units of Rnase
inhibitor, 0.5 mist dNTPs, and 200 U of MMLV reverse transcrip-
tase (Clontech Laboratories Inc., Palo Alto, CA, USA) at 42°C for
one hour. The reverse transcriptase was inactivated by heating for
five minutes at 94°C.
Polymerase chain reaction amplification and Southern
hybridization
Primers for the PCR were designed to flank at least one
putative intron site for rat ANP and -actin. For ANP, the sense
primer (5 '-GGCTCCTTCTCCATCACCAA-3') corresponded to
base pair 4 to 23, and the antisense primer (5'- TGTTATCTTCG-
GTACCG-3') corresponded to bp 445 to 461 of rat ANP eDNA.
For f3-actin, the sense primer (5'-CGTAAAGACCTCTATGC-
CAA-3') corresponded to bp 2748-2767, and the antisense primer
(5 '-AGCCATGCCAAATGTCTCAT-3') corresponded to bp
3203-3222 of rat f3-actin gene. The size of expected PCR products
was 458 bps for ANP and 349 bps for -actin. For amplification,
PCR was performed at a final concentration of 1>< PCR buffer (10
mM Tris-HC1, pH 8.3; 50 mist KCI; 1.5 mM MgCI2), 0.2 mM dNTP,
0.4 j.rM sense and antisense oligos, 2.0 units of Taq DNA poly-
merase (Boehringer Mannheim, Indianapolis, IN, USA) to a total
volume of 50 p1. The amplification cycles were 45 seconds at 94°C,
45 seconds at 60°C and 90 seconds at 72°C in a Perkin-Elmer
Cetus 9600 thermocycler (Perkin-Elmer Cetus, Norwalk, CT,
USA). The cycle for the amplification of ANP mRNA was
repeated 30 times for renal cortex and outer medulla, 22 times for
atria and ventricles as in our previous study [21]. The amplified
products were then electrophoresed on 1.8% agarose gels and
transferred to nylon membranes (Schleicher & Schuell Gmbl-I,
Dassel, Germany). The blots were hybridized with [32P] labeled,
randomly-primed, 426 bp rat ANP cDNA prepared by PCR
cloning of the rat atria extracts for 16 hours at 65°C, according to
the standard technique. After each hybridization, the blots were
washed twice in a solution containing 0.1% SDS and 2 X SSC for
15 minutes at 37°C, then twice in 0.1% SDS and 0.1 X SSC at
65°C. Blots were exposed to Kodak XAR (Eastman Kodak
Company, Rochester, NY, USA) film at —70°C. A radioisotope-
labeled probe for /3-actin used as an internal control was also
made by the primer extension method. After autoradiography, the
x-ray film was scanned by a laser densitometer (Molecular Dy-
namics, Sunnyvale, CA, USA), and the data analyzed by MD
ImageQuant software release version 3.22. The value obtained for
each ANP PCR product was normalized by its /3-actin levels. To
control the accuracy of RT-PCR followed by Southern hybridiza-
tion, serially diluted total RNA of heart and renal tissues were
subjected to RT-PCR amplification. Moreover, an intra-assay
variation of semiquantitative RT-PCR followed by Southern blot
analysis from renal tissues was tested.
Table 1. Characteristics of normal control (NC), untreated diabetes
(UT-DM), and insulin-treated diabetes (JT-DM) rats on the 42nd day
after the administration of citric buffer or streptozotocin
NC UT-DM IT-DM
Number 6 7 6
Change in body weight % 43.0 1.5 —9.7 2.0° 42.8 2.8°
Blood glucose mmol/liter 6.8 0.2 40.8 1.2° 8.3 1.3°
Kidney/body weight ratio 3.6 0.08 6.3 0.14° 3.7 O.O7
><io-
Plasma ANPfmol/nzl 13.6 2.1 27.6 2.8'
Plasma renin activity_ng/ml/hr 3.3 0.72 0.4 0.06!
Values are mean SEM.
°P <0.001, hp < 0.01 vs. NC
° p < 0.001, d P < 0.01 vs. UT-DM
Glomerular filtration rate study
Rats were anesthetized intraperitoneally with 50 mg/kg pento-
barbital sodium (Abbott Laboratories, Chicago, IL, USA) and
tracheostomized. A polyethylene (PE-50) catheter was inserted
into the left femoral artery for blood sampling and continuous
arterial blood pressure monitoring with a pressure transducer and
a writing recorder (Gould, Valley View, OH, USA). Catheters
were also placed in the left and right femoral veins for infusion of
inulin and plasma. Inulin (7%) in normal saline was infused via a
syringe pump (Stoelting, Wood Dale, IL, USA) at a rate of 1.2
mi/hr. To replace blood loss from surgery, rat plasma from
diabetic or normal rats, equivalent in volume to 1% of body wt,
was infused over 50 minutes, followed by a sustained infusion rate
of 0.6 mI/hr with supplementary isotonic saline to replace urinary
losses. Urine was collected from the left ureter by PE-lO cannu-
lation. After a 60-minute equilibration period, urine was collected
from the left ureteral catheter over 30-minute periods, and 200 j.rl
blood samples were collected for plasma inulin measurement at
the midpoint of each urine collection. The inulin in plasma and
urine was measured by the thiourea-resorcinol method [27].
Radioimmunoassay
ANP-like immunoreactivity of plasma and urine were deter-
mined by a specific radioimmunoassay (RIA; Peninsula Labora-
tories, Inc., Belmont, CA, USA) after extraction as in our previous
report [7, 21]. PRA was also measured using an RIA kit (Du Pont
Company, Boston, MA, USA).
Statistical analysis
Data were expressed as mean SEM. To test the differences
among the three groups, analysis of variance was performed. If a
difference was found, unpaired Student's t-test was used for
comparison between two groups. Linear regression analysis was
used to test the correlation between the urine ANP excretion rates
and urine sodium excretion rates and urine volume in normal
control rats and diabetic rats on days 2, 4, 7, 14 and 42. A P
value < 0.05 was considered statistically significant.
Results
The characteristics of NC, UT-DM and IT-DM on the 42nd day
are shown in Table 1. The mean blood glucose levels and kidney
weight/body wt ratio in UT-DM were significantly increased,
whereas body wt were significantly decreased as compared to NC.
Plasma ANP levels in untreated diabetic rats were increased,
16.3 5.5
3.1 0.22°
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Table 2. Daily urine volume, daily urinary sodium excretion, and
urinary AN? excretion of normal control (NC), untreated diabetes
(UT-DM), and insulin-treated diabetes (IT-DM) rats
NC
N=6 UT-DMN=7 IT-DMN=6
Urine volume mi/day
Day 0 16 2.1 19 2.9 17 1.8
2 17 1.0 103 49a 38 3.2a
4 15 1.5 165 9.2a 24 2.8c
7 18 1.0 153 7j 19 2.2c
14 22 1.5 147 12.5 25 3.2c
42 24 3.0 164 10.6 19 5.2
Urine sodium excretion
mmol/day
Day 0
2
1.3 0.12
0.8 0.04
1.4 0.05
1.4 0.10'
1.3 0.10
0.9
4 1.0 0.07 1.6 015b 1.3 0.15
7 1.2 0.16 1.7 0.10k 1.2 013d
14 1.2 0.12 1.6 009h 1.0 015d
42 1.2 0.17 1.6 012b 1.0 o.l6
Urine ANP excretion fmol/day
Day 0 17 1.4 26 1 25 2.4
2 25 3.2 580 89 88 12.0
4 34 3.7 2150 303 37 54C
7 36 4.9 3342 329 45 3.8c
14 41 5.0 3169 256 30 3.1c
42 35 3.2 2828 227 32 33C
Values are mean SCM.
P < 0.001, ' P < 0.05 vs. NC
°P < 0.001, 'P < 0.01 vs. UT-DM
whereas PRA were suppressed. All these changes in the UT-DM
were ameliorated in the IT-DM. As shown in Table 2, mean daily
urinary sodium excretion and urinary volume were significantly
increased day 2 after STZ induction and remained elevated for
the entire 42-day study period in diabetic rats as compared to
those in normal rats. The urinary ANP-Ll excretion rate was also
elevated in diabetic rats and ran parallel to changes in the urinary
sodium excretion rate and urine volume. Daily urinary ANP
excretion rates were significantly correlated with sodium excretion
rate (r 0.503, P < 0.05) and urine volume (r = 0.799, P < 0.01)
in normal rats, untreated diabetic rats and insulin-treated diabetic
rats on day 42. Significant correlation were also found between
urinary ANP excretion rates and urinary sodium excretion rates,
urine volume on days 2, 4, 7 and 14 in normal and diabetic rats
(data not shown). The elevations of daily urine volume, urinary
sodium excretion rate, and ANP-LI excretion returned to near
normal range in insulin-treated diabetic rats.
RT-PCR coupled with Southern blot analysis revealed a 458-bp
product from rat kidney and heart tissue RNA extracts. To
determine the relative changes in tissue ANP mRNA expression,
the yield of ANP PCR products was normalized to the amount of
/3-actin eDNA amplified from the same RT eDNA of tissue
samples. This method has been used by several investigators [28,
29]. The accuracy of the semiquantitative RT-PCR with Southern
blot analysis in this study was tested. Serial dilutions of 2.4 zg
RNA were subjected to RT-PCR amplification for ANP and
J3-actin, respectively. The correlation coefficients between RNA
concentrations and corresponding densities were r = 0.995 and
r = 0.996 from renal cortex, r = 0.967 and r = 0.949 from cardiac
ventricles for ANP and 13-actin genes (Fig. 1), respectively. The
1 2 3 4
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Fig. 1. The quality control of semi-quantitative PCR followed by Southern
blot analysis. Serial dilutions (6:1, 6:2, 6:3, 6:4, and 6:5) of 2.4 .rg RNA
from rat ventricle were subjected to RT-PCR amplification for 22 and 22
cycles for ANP and /3-actin, respectively. (A) Ethidium bromide stained
1.8% agarose gel containing PCR products amplified for 22 and 22 cycles
for ANP and j3-actin, respectively. (B) Southern blot analysis of PCR
products from (A). (C) To test intra-assay variation of RT-PCR amplifi-
cation followed by Southern blot analysis, 2 j.g RNA (N = 6) from rat
cortex were subjected to RT-PCR amplification for 30 and 22 temperature
cycles for AN? and /3-actin, respectively.
intra-assaytest of RT-PCR followed by Southern blot analysis in
renal cortex (Fig. 1) was done and the variation coefficients of
ANP and J3-actin mRNA were 6.2% and 6.9%, respectively.
Figure 2 shows the autoradiographs of RT-PCR amplification
of ANP and /3-actin mRNA in the renal cortex, outer medulla,
atrium and ventricle from diabetic and control rats on day 42. The
relative ratios of the densitometry measures of the PCR products
for ANP and 13-actin are shown in Figure 3. increases in the
relative ratio of PCR products for ANP and J3-actin mRNA from
renal cortex and outer medulla in UT-DM rats were found when
compared with those in NC rats. The relative ratio for ANP and
/3-actin PCR product in ventricle increased significantly, while that
in atrium decreased significantly in UT-DM rats. No significant
changes for AN? mRNA expression in the renal medulla, atrium
and ventricle were observed between IT-DM rats and NC rats.
Figure 4 represents the autoradiographs of RT-PCR amplifica-
tion of ANP and /3-actin mRNA in the renal cortex and outer
UT-DM IT-DM
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Fig. 2. Autoradiographs of the amplification of ANP and f3-actin mRNA by RT-PCR followed by Southern blot analysis in renal cortex, renal outer medulla,
atrium, and ventricle from 5 representative rats of normal controls (NC), untreated diabetic rats (UT-DM) and insulin-treated diabetic rats (IT-DM) on the
42nd day after the administration of citric buffer or streptozotocin. Each lane represent an individual rat.
medulla of NC rats on days 2 and 14 and of UT-DM rats on days
2, 4, 7 and 14 day. The relative ratio of the PCR products for ANP
and J3-actin mRNA in UT-DM rats significantly increased (P <
0.01) on the day 2 and remained elevated until day 14.
In Table 3, mean GFR value of UT-DM rats was not higher
than that of NC rats or that of IT-DM rats. Untreated diabetic
rats had a markedly elevated blood glucose value and decreased
body wt, whereas IT-DM rats had no difference in blood glucose
value or body wt as compared to NC rats. There was no difference
in mean arterial blood pressure among the three groups.
Discussion
In the present study, we demonstrated that the kidney is a site
of ANP synthesis and that renal ANP synthesis is enhanced in
diabetic rats, based on the following findings: (1) PCR amplifica-
tion identified the presence of ANP mRNA in the rat kidney; (2)
renal ANP mRNA expression was significantly increased in
diabetic rats; (3) urinary ANP-LI excretion was markedly in-
creased in diabetic rats as compared to that of control rats; and (4)
urinary ANP excretion rate correlated well with urine sodium
excretion and urine volume.
Although no measurement of plasma volume was done, the
increased plasma ANP level and reduced plasma renin activity in
Fig. 3. Relative ratios of the densitometiy readings for RT-PCR amplifica-
tion of AMP and -acrin mRS/A in the renal cortex, Outer medulla, atrium
and ventricle from the normal controls (LI, N = 6), untreated diabetic rats(B, N = 7) and insulin-treated diabetic rats (E:, N = 6) on the 42nd day
after the administration of citric buffer or streptozotocin. 'P < 0.01, P <
0.05 versus normal controls; 5P < 0.001, tp < 0.05 versus untreated
diabetic rats.
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diabetic rats were compatible with another report [221. The
increase of plasma ANP level has been thought to originate from
the atrium in response to sodium retention and volume expansion
[22-23]. However, our current study shows that diabetic rats have
increased cardiac ventricular ANP mRNA but decreased atrial
ANP mRNA levels. Actually, extra-atrial transcription of the
ANP gene has been identified in different organs [5—8], from
which ANP was released to participate in the regulation of blood
pressure and body fluid homeostasis [7—8]. In several pathophys-
iological conditions, plasma ANP levels correlated much better
with the changes in the expression of ANP gene in extra-atrial
tissues when compared to those in the atrium [30, 311]. These
observations support the proposal that extra-atrial ANP synthesis
might play a role in the regulation of volume and electrolyte
balance [32].
In the search of the renal ANP gene message, we found that the
renal ANP mRNA was too low to be measured by Northern blot
analysis. However, by using RT-PCR coupled with Southern blot
analysis, the presence of renal ANP mRNA message could easily
be detected. In this study, we compared the relative amount of
ANP mRNA expression in renal tissues. Our results have shown
that serial dilution of RNA followed by RT-PCR and Southern
blot analysis can detect relatively small changes in the mRNA
message. Our current study has also shown that renal ANP
mRNA was enhanced in diabetic rats as compared to that in
normal rats.
In addition to the changes of cardiac ANP mRNA levels, our
results have surprisingly showed that ANP mRNA expression in
renal cortex and outer medulla and urinary ANP-LI excretion
were markedly enhanced after the induction of diabetes. Several
recent studies have demonstrated that the kidney is also a site of
ANP synthesis [9—12] and that renal synthesized ANP is specu-
lated to be involved in the regulation of renal sodium excretion
[12]. Several investigations indicate that circulating ANP is not a
direct regulator of renal sodium excretion [13—18, 33]. In human
studies, renal natriuretic peptide (urodilatin) closely parallels
renal sodium excretion [16—18], while circulating ANP levels do
not correlate with the degree of natriuresis [13—16] in the various
conditions that influence body fluid regulation. More recently, we
have also demonstrated that renal ANP mRNA expression and
urinary ANP excretion rate were markedly increased in DOCA-
salt rats [21]. In DOCA-salt rats, urinary ANP excretion rate was
NC UT-DM IT-DM
Number 6 7 5
Body weight g
Blood glucose mmol/liter
Urine volume mi/day
436 6
6.2 0.2
21 1.6
276 6"
38.2 5.4"
158 12.8"
418 7b
5.3
26 2.7k'
Mean arterial pressure mm Hg 115 8.2 109 6.9 118 7.3
GFR mI/mm 1.55 0.26 160 0.16 1.64 0.21
also found to be significantly correlated with the urinary sodium
excretion rate. Taken together with these prior investigations,
significantly increased urinary ANP-Ll excretion and enhanced
renal AN? gene expression in diabetic rats shown in this study
suggest that ANP synthesized in the kidney is responsible for
sodium and water homeostasis. This is to say that the kidney itself
may sense and regulate fluid and electrolyte imbalance resulting
from diabetes by the synthesis of ANP.
Enhanced proximal tubule sodium-glucose cotransport activity,
osmotic effect of hyperglycemia and blunting of the volume reflex
have been recognized to be contributing factors of increased
intravascular volume and total body sodium in early diabetes
[34—36]. Circulating ANP levels from the heart therefore in-
creases in a counterregulatory response to increased intravascular
volume, and then may mediate glomerular hyperfiltration in
moderately hyperglycemic diabetic rats. This hypothesis was re-
cently confirmed by Zang et a! [34]. By infusion of ANP receptor
antagonist (HS-142-1) into diabetic rats, they found a significant
reduction of glomerular filtration from markedly elevated to
near-normal levels. However, in our study, elevated plasma AN?
concentration with unchanged glomerular filitration in severely
hyperglycemic diabetic rats were found. This finding is consistent
with another study [22]. Increased plasma ANP level without
glomerular hyperfiltration in severely hyperglycemic diabetic rats
may be explained by markedly increased renal arteriolar resis-
tance [37]. An increase of vasoconstrictive substances have been
found [38] and may counteract the direct action of natriuretic
peptides on renal hemodynamics in severely hyperglycemic dia-
betic rats. In other words, we may speculate that ANP may be very
important in the maintenance of GFR in the face of vasoconstric-
tor effects in severely hyperglycemic diabetic rats.
Osmotic diuresis due to hyperglycemia are the undisputed
finding observed immediately after the development of diabetes.
The unreabsorbed glucose, acting as an osmotic substance, inhib-
its the reabsorption of both water and sodium. Therefore, osmotic
diuresis has been thought as the most important contributing
factor to mediate diuresis and natriuresis in diabetes. Because
exogenous AN? administration may elicit a pronounced natri-
uretic effect mediated by increased filtered load and by decreased
tubule sodium reabsorption [3]. The increase of plasma ANP level
provides us to hypothesize that ANP may also be related to
natriuresis and diuresis in diabetes. Zang et al [34] demonstrated
that the acute administration of the ANP receptor antagonist
significantly reduced diuresis and natriuresis in diabetic rats.
Their results confirm that plasma ANP, in addition to osmotic
A
I II II II II II
NC DM DMDMDM NC
2 2 4 7 14 14 Time, days
—ANP
— f3-actin
Table 3. Laboratory data of 6 normal control (NC), 7 untreated
diabetic (U1-DM) and 5 insulin-treated diabetic (IT-DM) rats during
inulin clearance determination done from 4 to 6 weeks after the
injection of STZ or citric buffer
B
—ANP
Fig. 4. Autoradiographs of the amplification of AN? and 13-actin mR/VA by
RT-PCR followed by Southern blot analysis in renal cortex (A), outer medulla
(B) from normal controls (NC) and untreated diabetic rats (DM) on days 2,
4, 7 and 14 after citric buffer or streptozotocin injection.
— -actin Values are mean SCM.
"P < 0.001 vs. NC
b P < 0.001 vs. UT-DM
Shin et al: ANP mRNA in diabetic rat kidney 1105
dialysis, may contribute to natriuresis arid diuresis in early diabe-
tes. However, this does not exclude the possible contribution of
renal-synthesized ANP or other natriuretic peptides to diuresis or
natriuresis in diabetic rats. Specific studies to evaluate these issues
are currently in progress in our laboratory.
In conclusion, the present study has showed that the rat kidney
is a site of ANP synthesis and that renal ANP mRNA expression
is strongly enhanced in diabetic rats. Whether renal synthesized
ANP is one of factors to handle the regulation of water and
sodium balance in diabetic rats is worthy of further investigation.
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